The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer: A single-arm, phase II study (ALTER-C-002 trial).
 
Ke-Feng Ding
No Relationships to Disclose
 
Yue Liu
No Relationships to Disclose
 
Jiaqi Chen
No Relationships to Disclose
 
Lifeng Sun
No Relationships to Disclose
 
Dong Xu
No Relationships to Disclose
 
Xiujun Liao
No Relationships to Disclose
 
Qian Xiao
No Relationships to Disclose
 
JUN LI
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose